Fact CheckerSign in

NCT07138040Recruiting

Re-Engaging AYA Survivors in Cancer-Related Healthcare

Re-Engaging AYA Survivors in Cancer-Related Healthcare: A Sequential Multiple Assignment Randomized Trial

Source: ClinicalTrials.gov · Last updated 18 Feb 2026

Brief summary (registry, in English)

The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood cancer to promote re-engagement in cancer-related long-term follow-up care (LTFU). The main aims are: * To test the efficacy of adaptive interventions (AIs) that begin with low touch intervention (LTI) as compared to written information (WI) on attending an appointment, and self-reported self-management among AYA. * To identify the most efficacious second-stage strategy for those who initially schedule/attend an appointment (maintenance vs. step-up) and for those who do not (step-up vs. step-up maximum). * To assess multilevel factors contributing to the effects of re-engaging AYA and how best to integrate AIs into practice. Throughout the duration of the study, participants will complete four surveys, receive a series of interventions, and may be asked to participate in an interview (post-intervention).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
530 (estimated)
First submitted
15 Aug 2025
Start date
1 Aug 2025
Primary completion date
30 Apr 2028
Lead sponsor
Children's Hospital of Philadelphia
NCT number
NCT07138040

What you commit to

  • Study type: Interventional
  • Planned participants: 530
  • From 1 Aug 2025 to the primary completion date, 30 Apr 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received surgery only treatment

Other illness

  • Cognitive impairment limiting participation
  • Currently living with cancer diagnosis (either new, metastatic, recurrence, or relapse)

Other

  • Transferred to primary care
  • Absence of documentation of treatment history
  • Absence of inclusion criteria above
  • No involvement in the AYA's healthcare
  • AYA Decline support person's participation
  • Absence of inclusion criteria above

Who the study is looking for

  • 15-29 years old
  • History of a childhood cancer diagnosis, diagnosed prior to age 22
  • Has not had a cancer-related follow-up visit in at least 15 months (or is 3 months past recommended follow-up)
  • U.S. resident (not international patient)
  • Has previously attended a cancer-related appointment at Children's Hospital of Philadelphia, or Nationwide Children's Hospital or Penn
  • At least 2 years from end of treatment and 5 years from diagnosis
  • English proficient
  • For AYA under age 18, must have a caregiver to provide informed consent
  • Primary caregiver or other support person (e.g. partner, sibling, other caregiver)
  • At least 18 years old
  • U.S. resident
  • English proficient

Age in the registry: 15 years to 29 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nationwide Children's Hospital
Coordinator of this site? Confirm its status
ColumbusUnited StatesRecruiting
Penn Medicine
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Children's Hospital of Philadelphia
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.